MedTech Acquisition Corporation Unit
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch MTACU and buy or sell other stocks, ETFs, and their options commission-free!About MTACU
TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020, and is headquartered in Westminster, CO.
CEOMary T. Szela, MBA
CEOMary T. Szela, MBA
Employees110
Employees110
HeadquartersWestminster, Colorado
HeadquartersWestminster, Colorado
Founded
Founded
Employees110
Employees110
MTACU Key Statistics
Market cap431.11M
Market cap431.11M
Price-Earnings ratio-57.12
Price-Earnings ratio-57.12
Dividend yield—
Dividend yield—
Average volume475.20
Average volume475.20
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$11.43
52 Week high$11.43
52 Week low$9.23
52 Week low$9.23
Stock Snapshot
MedTech Acquisition Corporation Unit(MTACU) stock is priced at $11.35, giving the company a market capitalization of 431.11M. It carries a P/E multiple of -57.12.
During the trading day, MedTech Acquisition Corporation Unit(MTACU) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 475.2.
The stock's 52-week range extends from a low of $9.23 to a high of $11.43.
The stock's 52-week range extends from a low of $9.23 to a high of $11.43.